Stephen Mathai, MD, MHS explains the relationship that exists between pulmonary hypertension and connective tissue disease.
Stephen Mathai, MD, MHS discusses the various risks related to developing pulmonary hypertension if you have connective tissue disease.
Martha Kingman, D.N.P., FNP-C, and Jessica Humphrey, Pharm.D., BCPS, discuss the classifications of medications used to treat pulmonary hypertension (PH) and their side effects, interactions between common over-the-counter (OTC) medications and PH medications, and identifying the differences between cold, flu, allergy and COVID-19 symptoms in this webinar.
Jean M. Elwing, MD presents information on the basics of PH, how PH is defined and the types and classifications of PH.
Jean M. Elwing, MD discusses the different types of PH and the reasons behind the extensive testing that is required for an accurate PH diagnosis. An explanation of the available treatments for each type of PH and considerations that your PH care team makes when choosing the best treatment plan for you is presented.”
Melanie K. Nies, MD, talks about why pediatric research is important, how it is different than research in adults and things to know when considering participation in pediatric research for your child.
Daniel C. Grinnan, MD, provides an overview of how new medications are developed.